University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
University of Tennessee Health Science Center, Memphis, Tennessee.
Clin Gastroenterol Hepatol. 2017 Aug;15(8):1191-1194. doi: 10.1016/j.cgh.2017.05.013. Epub 2017 May 18.
Functional dyspepsia remains a major challenge for clinicians with no approved drugs available in the Western World. In October 2016, a meeting was held in Washington, DC, sponsored by the American Gastroenterological Association's Center for Diagnostics and Therapeutics, which included members of the Food and Drug Administration (FDA) and the pharmaceutical industry, experts in FD, and representatives of patient organizations. This white paper summarizes our current status, progress with a validated patient reported outcome instrument in functional dyspepsia, future directions and needs.
功能性消化不良仍然是临床医生面临的主要挑战，在西方世界尚无获得批准的药物。2016 年 10 月，在美国胃肠病学协会诊断和治疗中心的赞助下，在华盛顿特区举行了一次会议，会议成员包括美国食品和药物管理局（FDA）和制药行业、功能性消化不良专家以及患者组织的代表。本白皮书总结了我们目前的状况、在功能性消化不良中验证患者报告结局工具方面的进展、未来的方向和需求。
